Skip to content
healthcare.dev

Starjemza

NDC 0143-9169, ustekinumab-hmny, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0143-9169
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761419
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9169 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB45 mg/.5mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
0143-9169-0100143916901.5 mL in 1 VIAL (0143-9169-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8b72aa27-82cc-4c1b-be43-8b50e5e3d737

Use it

Look up 0143-9169 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0143-9169 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0143-9169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.